Mônica Regina Favre
Research Subjects
Mônica Regina Favre has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Henry Markram
A Blue Brain Project, Brain and Mind Institute , EPFL, Campus Biotech , Geneva , Switzerland
2 shared publications- Kamila Markram
Laboratory of Neural Microcircuits, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne Lausanne, Switzerland
2 shared publications Deborah Ela Mendola
Laboratory of Neural Microcircuits, Brain Mind Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
1 shared publication- Deborah LaMendola
Laboratory of Neural Microcircuits, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne Lausanne, Switzerland
1 shared publication Dimitri Echristodoulou
Laboratory of Neural Microcircuits, Brain Mind Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
1 shared publication- Georges Khazen
Lebanese American University
1 shared publication
Latest Publications
- 27 March 2019
- Published by Taylor & Francis in Cognitive Neuroscience
- Vol. 10 (3) , 171-173
Individual differences in sensory sensitivity: Further lessons from an Autism model
In this commentary, we join Ward (2018) in the usefulness of conceptualizing neural output in terms of signal and noise relationships, to create the missing links between neural, behavioral and subjective sensory sensitivity. We draw from our work in the Intense World Theory of Autism and the VPA rodent model, to complement the discussion the consideration of developmental time and function of the system, for a neural output to serve as a predictor of atypical outcome in sensory sensitivity, and guide personalized therapies.
- 27 March 2019
- Published by Taylor & Francis in Cognitive Neuroscience
- Vol. 10 (3) , 171-173
Individual differences in sensory sensitivity: Further lessons from an Autism model
In this commentary, we join Ward (2018) in the usefulness of conceptualizing neural output in terms of signal and noise relationships, to create the missing links between neural, behavioral and subjective sensory sensitivity. We draw from our work in the Intense World Theory of Autism and the VPA rodent model, to complement the discussion the consideration of developmental time and function of the system, for a neural output to serve as a predictor of atypical outcome in sensory sensitivity, and guide personalized therapies.
- Open Access
- 2 June 2015
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 9, 127
Predictable enriched environment prevents development of hyper-emotionality in the VPA rat model of autism
Understanding the effects of environmental stimulation in autism can improve therapeutic interventions against debilitating sensory overload, social withdrawal, fear and anxiety. Here, we evaluate the role of environmental predictability on behavior and protein expression, and inter-individual differences, in the valproic acid (VPA) model of autism. Male rats embryonically exposed (E11.5) either to VPA, a known autism risk factor in humans, or to saline, were housed from weaning into adulthood in a standard laboratory environment, an unpredictably enriched environment, or a predictably enriched environment. Animals were tested for sociability, nociception, stereotypy, fear conditioning and anxiety, and for tissue content of glutamate signaling proteins in the primary somatosensory cortex, hippocampus and amygdala, and of corticosterone in plasma, amygdala and hippocampus. Standard group analyses on separate measures were complemented with a composite emotionality score, using Cronbach’s Alpha analysis, and with multivariate profiling of individual animals, using Hierarchical Cluster Analysis. We found that predictable environmental enrichment prevented the development of hyper-emotionality in the VPA-exposed group, while unpredictable enrichment did not. Individual variation in the severity of the autistic-like symptoms (fear, anxiety, social withdrawal and sensory abnormalities) correlated with neurochemical profiles, and predicted their responsiveness to predictability in the environment. In saline-exposed animals, the association between socio-affective behaviors, neurochemical profiles and environmental predictability was negligible. This study suggests that rearing in a predictable environment prevents the development of hyper-emotional features in animals exposed to an autism risk factor, and demonstrates that unpredictable environments can lead to negative outcomes, even in the presence of environmental enrichment.
- 2 June 2015
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 9, 127
Open AccessPredictable enriched environment prevents development of hyper-emotionality in the VPA rat model of autism
Understanding the effects of environmental stimulation in autism can improve therapeutic interventions against debilitating sensory overload, social withdrawal, fear and anxiety. Here, we evaluate the role of environmental predictability on behavior and protein expression, and inter-individual differences, in the valproic acid (VPA) model of autism. Male rats embryonically exposed (E11.5) either to VPA, a known autism risk factor in humans, or to saline, were housed from weaning into adulthood in a standard laboratory environment, an unpredictably enriched environment, or a predictably enriched environment. Animals were tested for sociability, nociception, stereotypy, fear conditioning and anxiety, and for tissue content of glutamate signaling proteins in the primary somatosensory cortex, hippocampus and amygdala, and of corticosterone in plasma, amygdala and hippocampus. Standard group analyses on separate measures were complemented with a composite emotionality score, using Cronbach’s Alpha analysis, and with multivariate profiling of individual animals, using Hierarchical Cluster Analysis. We found that predictable environmental enrichment prevented the development of hyper-emotionality in the VPA-exposed group, while unpredictable enrichment did not. Individual variation in the severity of the autistic-like symptoms (fear, anxiety, social withdrawal and sensory abnormalities) correlated with neurochemical profiles, and predicted their responsiveness to predictability in the environment. In saline-exposed animals, the association between socio-affective behaviors, neurochemical profiles and environmental predictability was negligible. This study suggests that rearing in a predictable environment prevents the development of hyper-emotional features in animals exposed to an autism risk factor, and demonstrates that unpredictable environments can lead to negative outcomes, even in the presence of environmental enrichment.
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 7, 88
General developmental health in the VPA-rat model of autism
Autism is a neurodevelopmental condition diagnosed by impaired social interaction, abnormal communication and, stereotyped behaviors. While post-mortem and imaging studies have provided good insights into the neurobiological symptomology of autism, animal models can be used to study the neuroanatomical, neurophysiological and molecular mediators in more detail and in a more controlled environment. The valproic acid (VPA) rat model is an environmentally triggered model with strong construct and clinical validity. It is based on VPA teratogenicity in humans, where mothers who are medicated with VPA during early pregnancy show an increased risk for giving birth to an autistic child. In rats, early embryonic exposure, around the time of neural tube closure, leads to autism-like anatomical and behavioral abnormalities in the offspring. Considering the increasing use of the VPA rat model, we present our observations of the general health of Wistar dams treated with a single intraperitoneal injection of 500 or, 600 mg/kg VPA on embryonic day E12.5, as well as their male and female offspring, in comparison to saline-exposed controls. We report increased rates of complete fetal reabsorption after both VPA doses. VPA 500 mg/kg showed no effect on dam body weight during pregnancy or, on litter size. Offspring exposed to VPA 500 mg/kg showed smaller brain mass on postnatal days 1 (P1) and 14 (P14), in addition to abnormal nest seeking behavior at P10 in the olfactory discrimination test, relative to controls. We also report increased rates of physical malformations in the offspring, rare occurrences of chromodacryorrhea and, developmentally similar body mass gain. Further documentation of developmental health may guide sub-grouping of individuals in a way to better predict core symptom severity.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 7, 88
Open AccessGeneral developmental health in the VPA-rat model of autism
Autism is a neurodevelopmental condition diagnosed by impaired social interaction, abnormal communication and, stereotyped behaviors. While post-mortem and imaging studies have provided good insights into the neurobiological symptomology of autism, animal models can be used to study the neuroanatomical, neurophysiological and molecular mediators in more detail and in a more controlled environment. The valproic acid (VPA) rat model is an environmentally triggered model with strong construct and clinical validity. It is based on VPA teratogenicity in humans, where mothers who are medicated with VPA during early pregnancy show an increased risk for giving birth to an autistic child. In rats, early embryonic exposure, around the time of neural tube closure, leads to autism-like anatomical and behavioral abnormalities in the offspring. Considering the increasing use of the VPA rat model, we present our observations of the general health of Wistar dams treated with a single intraperitoneal injection of 500 or, 600 mg/kg VPA on embryonic day E12.5, as well as their male and female offspring, in comparison to saline-exposed controls. We report increased rates of complete fetal reabsorption after both VPA doses. VPA 500 mg/kg showed no effect on dam body weight during pregnancy or, on litter size. Offspring exposed to VPA 500 mg/kg showed smaller brain mass on postnatal days 1 (P1) and 14 (P14), in addition to abnormal nest seeking behavior at P10 in the olfactory discrimination test, relative to controls. We also report increased rates of physical malformations in the offspring, rare occurrences of chromodacryorrhea and, developmentally similar body mass gain. Further documentation of developmental health may guide sub-grouping of individuals in a way to better predict core symptom severity.